Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination
Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination
复制标题
DOI:
10.1016/j.molbiopara.2006.06.014
复制
发表时间:
2006-11-01
影响因子:
1.5
通讯作者:
Cowman, Alan F.
中科院分区:
文献类型:
--
作者:
Maier, Alexander G.;Braks, Joanna A. M.;Cowman, Alan F.
The ability to genetically manipulatePlasmodium falciparum has been established for a number of years and it is an important tool for functional analysis of parasite genes using gene disruption [1], allelic exchange [2] and transgene expression [3]. This was established using positive selection for maintenance of circular plasmids carrying a drug selectable marker such as Toxoplasma gondii dihydrofolate reductase (TgDHFR)[4, 5], or the human dhfr gene [6] conferring resistance to pyrimethamine or WR99210 respectively although more recently other selection systems have been used [7]. Transfected P. falciparum parasites carrying copies of these plasmids integrated into the genome by homologous recombination were generally selected over time by cycles of growth on and off drug selection. The episomal plasmids are lost rapidly in the absence of drug selection as they are partitioned unevenly amongst the daughter progeny whereas the plasmids integrated into the genome are segregated normally with each chromosome [8]. This method ensured that after subsequent on/off drug cycles all transfected P. falciparum parasites obtained had integrated the plasmid by single crossover homologous recombination. Whilst this proved to be an extremely useful method for gene disruption it was limited because of the long periods of culture required to derive parasites with integrated copies of the plasmid due to persistence of the circular episomal forms. Another drawback is that with a single cross over theAbbreviations: CD, cytosine deaminase; DHFR, dihydrofolate reductase; 5-FC, 5-fluorocytosine; FCU, chimeric gene of Saccharomyces cerevisiae CD and URPT; TK, thymidine kinase; URPT, uracil phosphoribosyl transferase∗ Corresponding author at: The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Melbourne 3050, Australia. Tel.:+ 61 3 93452446; fax:+ 61 3 93470852.